Poda to Commence PMTA Process in the USA
Retrieved on:
Tuesday, August 24, 2021
Company, FSE, Population, Comment, Federal Food, Drug, and Cosmetic Act, Pre-consultation Agreement (Japan), CSE, Public affairs, Smoking, Smokeless tobacco, Tobacco, Method, Public policy, Canadian General Electric, Smoker, Government Affairs Institute, Smell, Government, Canadian Securities Exchange, Nick, Food, Marketing, Heat, ALL, HNB, Multimedia, Public health, Board, FD, US FDA, NKO, Vail v. Juul Labs, Inc., Adult, OTC, News, Head, CEO, Wellness, US Foods, Corporate Affairs, US, Smoke, View, Pharmaceutical industry, Financial adviser
Pursuant to the Consulting Agreement, NKO will help to coordinate and oversee the entire PMTA process for certain Poda products.
Key Points:
- Pursuant to the Consulting Agreement, NKO will help to coordinate and oversee the entire PMTA process for certain Poda products.
- Prior to receiving PMTA approval, however, Poda may be able to sell certain of its products in the USA that are not subject to PMTA authorization requirements.
- Ryan Selby, CEO, commented, "Obtaining PMTA approval in the USA for certain Poda products is an important goal for the Company.
- Obtaining marketing authorization under the PMTA for certain Poda products in the USA will allow us to expand our offerings in this Country."